New drug candidate kills lung cancer cells in lab tests

Researchers have identified a small molecule called KAN0441571C that triggers cell death in non-small cell lung cancer, one of the deadliest cancer types. The finding could point toward a new treatment approach, though human trials are needed to determine whether the drug works in patients.

Originaltitel: A Small Molecule Targeting the Intracellular Tyrosine Kinase Domain of ROR1 (KAN0441571C) Induced Significant Apoptosis of Non-Small Cell Lung Cancer (NSCLC) Cells